Prestige Consumer Healthcare (PBH) Capital Leases (2019 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Capital Leases of $18.7 million in Q4 2025, down 3.45% quarter-over-quarter from $19.3 million in Q3 2025, and up 357.49% on a YoY basis from $4.1 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Capital Leases (2019 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Capital Leases history runs 7 years deep, the most recent figure standing at $18.7 million for Q4 2025.
- In Q4 2025, Capital Leases rose 357.49% year-over-year to $18.7 million; the TTM figure through Dec 2025 stood at $18.7 million (up 357.49% YoY), while the FY2025 annual figure was $20.6 million, up 11890.7% from the prior year.
- Capital Leases was $18.7 million for Q4 2025 at Prestige Consumer Healthcare, down from $19.3 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $20.6 million in Q1 2025 to a low of $126000.0 in Q3 2024.
- Historically, Capital Leases has averaged $6.2 million across 5 years, with a median of $3.9 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Capital Leases tumbled 92.95% in 2023, then surged 15232.54% in 2025.
- A 5-year view of Capital Leases shows it stood at $4.8 million in 2021, then plunged by 50.61% to $2.4 million in 2022, then tumbled by 91.82% to $195000.0 in 2023, then soared by 1990.77% to $4.1 million in 2024, then surged by 357.49% to $18.7 million in 2025.
- The last three Capital Leases figures came in at $18.7 million (Q4 2025), $19.3 million (Q3 2025), and $20.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.65 Mn |
| Sep 30, 2025 | 19.32 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Mar 31, 2025 | 20.62 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 172,000.00 |
| Dec 31, 2023 | 195,000.00 |
| Sep 30, 2023 | 218,000.00 |
| Jun 30, 2023 | 945,000.00 |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 3.09 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 4.50 Mn |
| Dec 31, 2021 | 4.83 Mn |
| Sep 30, 2021 | 5.49 Mn |
| Jun 30, 2021 | 6.16 Mn |
| Mar 31, 2021 | 6.82 Mn |